Medplus soars over 19% on robust Q4 earnings; records largest single-day gain since listing

Following the robust Q4 numbers, the stock got off to a strong start, opening at ₹738 as against the previous day's closing price of ₹689. It then climbed further, reaching an intraday high of ₹824 in early trade or 19.59% higher, marking the largest intraday gain since listing.

Medplus Health Services jumps 28% from 52-week low; will the rally continue?

The stock rebounded strongly after reaching a 52-week low of ₹548.25, and it is now up 28.31 percent from the one-year low levels. Nonetheless, the stock is down 11.6 percent from its IPO price of ₹796. At the current price, the stock is down 47.62 percent from its all-time high of ₹1,343.

MedPlus Health Services is at an all-time low; slips 27% from the IPO price; top brokerage says 'buy'

Despite MedPlus Health Services' weak performance, Japanese brokerage firm Nomura is bullish on the stock. The brokerage has initiated coverage on the stock with a 'buy' call at a target price of ₹925/share. Nomura forecasts revenue of CAGAR 26.9 percent over the financial year 2022-2025.

Top Medplus Health Services News

markets

Medplus soars over 19% on robust Q4 earnings; records largest single-day gain since listing

markets

Medplus Health Services jumps 28% from 52-week low; will the rally continue?

markets

MedPlus Health Services is at an all-time low; slips 27% from the IPO price; top brokerage says 'buy'